BioSpace News Archive

Business

PictorLabs Reimagines Histopathology with AI, Starting with Cancer

PictorLabs emerged from stealth mode Thursday with $18.8 million to advance its AI-powered virtual staining platform that researchers hope will “reimagine the future” of histopathology.

December 1, 2022
·
2 min read
·
Rosemary Scott
Business

Pfizer and Roivant Launch Another Vant with an Initial Focus on Ulcerative Colitis

Pfizer and Roivant have joined forces to form yet another Vant. The new entity will initially work to commercialize RVT-3101 for ulcerative colitis.

December 1, 2022
·
2 min read
·
Mark Terry
Drug Development

Athira’s Alzheimer’s Therapy Climbs Ranks in a Competitive Space

Athira Pharma’s experimental Alzheimer’s therapy, fosgonimeton, continues to show signs of being able to improve cognition and function in patients.

December 1, 2022
·
2 min read
·
Alex Keown
Drug Development

SQZ Culls 60% of Workforce as Founder & CEO Steps Down

SQZ Biotechnologies is slashing 60% of its workforce and looking for a new CEO after initiating a strategic prioritization to focus on its cell therapy platform for solid tumors.

December 1, 2022
·
2 min read
·
Alex Keown
Drug Development

Lilly’s Donanemab Shines vs. Aduhelm in First Active Comparator Study (Updated)

Eli Lilly’s investigational antibody donanemab met all of its primary and secondary endpoints in the Phase III TRAILBLAZER-ALZ 4 study, the company announced Wednesday.

December 1, 2022
·
3 min read
·
Tristan Manalac
Genetown

TScan Therapeutics Named the Highest-Placed Midsize Biotechnology Company in The Top Places to Work for 2022 by The Boston Globe

TScan Therapeutics, Inc. announced it has been named one of the Top Places to Work in Massachusetts in the 15th annual employee-based survey project from The Boston Globe.

December 1, 2022
·
4 min read
Business

Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases

Roivant Sciences (Nasdaq: ROIV) and Pfizer Inc. today announced formation of a new Vant to develop and commercialize PF-06480605 (now RVT-3101).

December 1, 2022
·
9 min read
SHL Telemedicine to present at Ladenburg Thalmann Virtual Technology Expo on December 7th

SHL Telemedicine Ltd. today announced that it will be presenting virtually at the upcoming Ladenburg Thalmann Virtual Technology Expo on Wednesday, December 7th, at 9:30 AM ET / 3:30 PM CET.

December 1, 2022
·
1 min read
Policy

Brazilian Regulatory Authority Grants Approval for Waylivra™ for Familial Partial Lipodystrophy

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved Waylivra™ (volanesorsen) as the first treatment for familial partial lipodystrophy (FPL) in Brazil.

December 1, 2022
·
7 min read
Genetown

Charles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection

Charles River Laboratories International, Inc. (NYSE: CRL) launches the Endosafe ® Nexus 200™ , expanding its robust endotoxin testing portfolio.

December 1, 2022
·
3 min read